{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:08:28Z","timestamp":1790014108928,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001123"],"award-info":[{"award-number":["AI001123"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["KL2 TR001413-07"],"award-info":[{"award-number":["KL2 TR001413-07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptococcal meningoencephalitis can occur in both previously healthy and immunocompromised hosts. Here, we describe a 55 year-old HIV-negative male with no known prior medical problems, who presented with three months of worsening headaches, confusion, and memory changes without fever. Magnetic resonance imaging of the brain demonstrated bilateral enlargement\/enhancement of the choroid plexi, with hydrocephalus, temporal and occipital horn entrapments, as well as marked periventricular transependymal cerebrospinal fluid (CSF) seepage. CSF analysis yielded a lymphocytic pleocytosis and cryptococcal antigen titer of 1:160 but sterile fungal cultures. Despite standard antifungal therapy and CSF drainage, the patient had worsening confusion and persistently elevated intracranial pressures. External ventricular drainage led to improved mental status but only with valve settings at negative values. Ventriculoperitoneal shunt placement could thus not be considered due to a requirement for drainage into the positive pressure venous system. Due to this persistent CSF inflammation and cerebral circulation obstruction, the patient required transfer to the National Institute of Health. He was treated for cryptococcal post-infectious inflammatory response syndrome with pulse-taper corticosteroid therapy, with resultant reductions in CSF pressures along with decreased protein and obstructive material, allowing successful shunt placement. After tapering of corticosteroids, the patient recovered without sequelae. This case highlights (1) the necessity to consider cryptococcal meningitis as a rare cause of neurological deterioration in the absence of fever even in apparently immunocompetent individuals and (2) the potential for obstructive phenomena from inflammatory sequelae and the prompt response to corticosteroid therapy.<\/jats:p>","DOI":"10.1186\/s12879-023-08349-y","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:02:19Z","timestamp":1686733339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammad","family":"El-Atoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hargarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ssebambulidde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Chittiboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seher H.","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth R.","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"8349_CR1","doi-asserted-by":"publisher","unstructured":"Maziarz EK, Perfect JR, Cryptococcosis. Infectious disease clinics of North America. 2016;30(1):179\u2013206. doi: https:\/\/doi.org\/10.1016\/j.idc.2015.10.006. PubMed PMID: 26897067; PubMed Central PMCID: PMC5808417.","DOI":"10.1016\/j.idc.2015.10.006"},{"key":"8349_CR2","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Eighth edition. ed. 2 volumes p."},{"issue":"5","key":"8349_CR3","doi-asserted-by":"publisher","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","volume":"11","author":"AA Panackal","year":"2015","unstructured":"Panackal AA, Wuest SC, Lin YC, Wu T, Zhang N, Kosa P, et al. Paradoxical Immune responses in Non-HIV cryptococcal meningitis. PLoS Pathog. 2015;11(5):e1004884. https:\/\/doi.org\/10.1371\/journal.ppat.1004884. PubMed PMID: 26020932; PubMed Central PMCID: PMC4447450.","journal-title":"PLoS Pathog"},{"issue":"3","key":"8349_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12281-019-00345-7","volume":"13","author":"S Anjum","year":"2019","unstructured":"Anjum S, Williamson PR. Clinical aspects of Immune damage in Cryptococcosis. Curr fungal Infect Rep. 2019;13(3):99\u2013108. https:\/\/doi.org\/10.1007\/s12281-019-00345-7. PubMed PMID: 33101578; PubMed Central PMCID: PMC7580832.","journal-title":"Curr fungal Infect Rep"},{"issue":"2","key":"8349_CR5","doi-asserted-by":"publisher","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","volume":"8","author":"V Pyrgos","year":"2013","unstructured":"Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the US: 1997\u20132009. PLoS ONE. 2013;8(2):e56269. https:\/\/doi.org\/10.1371\/journal.pone.0056269. PubMed PMID: 23457543; PubMed Central PMCID: PMC3574138.","journal-title":"PLoS ONE"},{"issue":"3","key":"8349_CR6","doi-asserted-by":"publisher","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","volume":"8","author":"KD Brizendine","year":"2013","unstructured":"Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS ONE. 2013;8(3):e60431. https:\/\/doi.org\/10.1371\/journal.pone.0060431. PubMed PMID: 23555970; PubMed Central PMCID: PMC3608592.","journal-title":"PLoS ONE"},{"issue":"5","key":"8349_CR7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect diseases: official publication Infect Dis Soc Am. 2001;33(5):690\u20139. 10.1086\/322597. PubMed PMID: 11477526.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"6","key":"8349_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","volume":"133","author":"JA DeSimone","year":"2000","unstructured":"DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133(6):447\u201354. https:\/\/doi.org\/10.7326\/0003-4819-133-6-200009190-00013. PubMed PMID: 10975963.","journal-title":"Ann Intern Med"},{"issue":"8","key":"8349_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1086\/383034","volume":"38","author":"HH Hirsch","year":"2004","unstructured":"Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect diseases: official publication Infect Dis Soc Am. 2004;38(8):1159\u201366. 10.1086\/383034. PubMed PMID: 15095223.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"key":"8349_CR10","doi-asserted-by":"publisher","unstructured":"Neal LM, Xing E, Xu J, Kolbe JL, Osterholzer JJ, Segal BM, et al. CD4(+) T cells orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio. 2017;8(6). https:\/\/doi.org\/10.1128\/mBio.01415-17. PubMed PMID: 29162707; PubMed Central PMCID: PMC5698549.","DOI":"10.1128\/mBio.01415-17"},{"issue":"9","key":"8349_CR11","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1093\/cid\/ciaa1901","volume":"73","author":"S Anjum","year":"2021","unstructured":"Anjum S, Dean O, Kosa P, Magone MT, King KA, Fitzgibbon E, et al. Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for post-infectious inflammatory syndrome. Clin Infect diseases: official publication Infect Dis Soc Am. 2021;73(9):e2789\u2013e98. https:\/\/doi.org\/10.1093\/cid\/ciaa1901. PubMed PMID: 33383587; PubMed Central PMCID: PMC8563180.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"10","key":"8349_CR12","doi-asserted-by":"publisher","first-page":"e0008651","DOI":"10.1371\/journal.pntd.0008651","volume":"14","author":"S Pharkjaksu","year":"2020","unstructured":"Pharkjaksu S, Kwon-Chung KJ, Bennett JE, Ngamskulrungroj P. Population diversity and virulence characteristics of Cryptococcus neoformans\/C. gattii species complexes isolated during the pre-HIV-pandemic era. PLoS Negl Trop Dis. 2020;14(10):e0008651. https:\/\/doi.org\/10.1371\/journal.pntd.0008651. Epub 20201005.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"8349_CR13","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","volume":"190","author":"LB Rosen","year":"2013","unstructured":"Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190(8):3959\u201366. https:\/\/doi.org\/10.4049\/jimmunol.1202526. PubMed PMID: 23509356; PubMed Central PMCID: PMC3675663.","journal-title":"J Immunol"},{"issue":"1","key":"8349_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat reviews Neurol. 2017;13(1):13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2016.167. PubMed PMID: 27886201.","journal-title":"Nat reviews Neurol"},{"key":"8349_CR15","doi-asserted-by":"crossref","unstructured":"Perfect JR, Casadevall A, Cryptococcosis. Infectious disease clinics of North America. 2002;16(4):837 \u2013 74, v-vi. doi: 10.1016\/s0891-5520(02)00036-3. PubMed PMID: 12512184.","DOI":"10.1016\/S0891-5520(02)00036-3"},{"issue":"2","key":"8349_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/ciz193","volume":"70","author":"KA Marr","year":"2020","unstructured":"Marr KA, Sun Y, Spec A, Lu N, Panackal A, Bennett J, et al. A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative people in the United States. Clin Infect Dis. 2020;70(2):252\u201361. https:\/\/doi.org\/10.1093\/cid\/ciz193. Epub 2019\/03\/12.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"8349_CR17","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/mmy\/myy154","volume":"57","author":"L Xu","year":"2019","unstructured":"Xu L, Zhang X, Guo Y, Tao R, Dai X, Yang Z, et al. Unique clinical features of cryptococcal meningitis among chinese patients without predisposing diseases against patients with predisposing diseases. Med Mycol. 2019;57(8):944\u201353. https:\/\/doi.org\/10.1093\/mmy\/myy154. PubMed PMID: 30657946.","journal-title":"Med Mycol"},{"issue":"2","key":"8349_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","volume":"14","author":"RC May","year":"2016","unstructured":"May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106\u201317. https:\/\/doi.org\/10.1038\/nrmicro.2015.6. PubMed PMID: 26685750; PubMed Central PMCID: PMC5019959.","journal-title":"Nat Rev Microbiol"},{"key":"8349_CR19","doi-asserted-by":"crossref","unstructured":"Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis. Journal of neurosurgery. 2016;125(1):177 \u2013 86. doi: 10.3171\/2015.4.JNS15255. PubMed PMID: 26517766.","DOI":"10.3171\/2015.4.JNS15255"},{"issue":"7","key":"8349_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.5588\/ijtld.17.0008","volume":"22","author":"AS Kamat","year":"2018","unstructured":"Kamat AS, Gretschel A, Vlok AJ, Solomons R. CSF protein concentration associated with ventriculoperitoneal shunt obstruction in tuberculous meningitis. Int J tuberculosis lung disease: official J Int Union against Tuberculosis Lung Disease. 2018;22(7):788\u201392. https:\/\/doi.org\/10.5588\/ijtld.17.0008. PubMed PMID: 29914605.","journal-title":"Int J tuberculosis lung disease: official J Int Union against Tuberculosis Lung Disease"},{"key":"8349_CR21","doi-asserted-by":"publisher","unstructured":"Mehta GU, Panackal AA, Murayi R, Bennett JE, Williamson PR, Chittiboina P. Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. Journal of neurology, neurosurgery, and psychiatry. 2018;89(2):219\u201320. doi: https:\/\/doi.org\/10.1136\/jnnp-2017-315830. PubMed PMID: 28550070; PubMed Central PMCID: PMC5702587.","DOI":"10.1136\/jnnp-2017-315830"},{"key":"8349_CR22","doi-asserted-by":"publisher","first-page":"752856","DOI":"10.3389\/fimmu.2021.752856","volume":"12","author":"A Ataya","year":"2021","unstructured":"Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The role of GM-CSF Autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: a concise review. Front Immunol. 2021;12:752856. https:\/\/doi.org\/10.3389\/fimmu.2021.752856. PubMed PMID: 34880857; PubMed Central PMCID: PMC8647160.","journal-title":"Front Immunol"},{"issue":"5","key":"8349_CR23","doi-asserted-by":"publisher","first-page":"e0270821","DOI":"10.1128\/mBio.02708-21","volume":"12","author":"DH Yang","year":"2021","unstructured":"Yang DH, England MR, Salvator H, Anjum S, Park YD, Marr KA, et al. Cryptococcus gattii Species Complex as an opportunistic Pathogen: Underlying Medical Conditions Associated with the infection. mBio. 2021;12(5):e0270821. https:\/\/doi.org\/10.1128\/mBio.02708-21. PubMed PMID: 34700378; PubMed Central PMCID: PMC8546560.","journal-title":"mBio"},{"issue":"2","key":"8349_CR24","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","volume":"5","author":"T Saijo","year":"2014","unstructured":"Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. mBio. 2014;5(2):e00912\u201314. https:\/\/doi.org\/10.1128\/mBio.00912-14. PubMed PMID: 24643864; PubMed Central PMCID: PMC3967522.","journal-title":"mBio"},{"issue":"2","key":"8349_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cid\/ciab920","volume":"75","author":"PH Kuo","year":"2022","unstructured":"Kuo PH, Wu UI, Pan YH, Wang JT, Wang YC, Sun HY, et al. Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with Central Nervous System and localized cryptococcosis: Longitudinal Follow-up and Literature Review. Clin Infect diseases: official publication Infect Dis Soc Am. 2022;75(2):278\u201387. https:\/\/doi.org\/10.1093\/cid\/ciab920. PubMed PMID: 34718451.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"1","key":"8349_CR26","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-017-09694-0","volume":"7","author":"DA Hammoud","year":"2017","unstructured":"Hammoud DA, Mahdi E, Panackal AA, Wakim P, Sheikh V, Sereti I, et al. Choroid Plexitis and Ependymitis by magnetic resonance imaging are biomarkers of neuronal damage and inflammation in HIV-negative cryptococcal meningoencephalitis. Sci Rep. 2017;7(1):9184. https:\/\/doi.org\/10.1038\/s41598-017-09694-0. Epub 20170823.","journal-title":"Sci Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08349-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:02:28Z","timestamp":1686733348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8349"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08349-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The National Institute of Allergy and Infectious Diseases (NIAID) Institutional Review Board (IRB) approved this study under NIAID Protocol number 93-I-0106. The subject provided written informed consent directly.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"407"}}